Humulin,recombinant human insulin- a form of insulin (trade name Humulin) made from recombinant DNA that is identical to human insulin; used to treat diabetics who are allergic to preparations made from beef or pork insulin hypoglycaemic agent,hypoglycemic agent- any of various agents that decrease...
Human insulin was the first recombinant biopharmaceutical approved in the US in 1982. Prior to that, protein products approved for use in humans were extracted from natural sources. Thus the discovery of new biopharmaceuticals occurred at a rather leisurely pace. However, the tools of molecular biol...
Humulin,recombinant human insulin- a form of insulin (trade name Humulin) made from recombinant DNA that is identical to human insulin; used to treat diabetics who are allergic to preparations made from beef or pork insulin hypoglycaemic agent,hypoglycemic agent- any of various agents that decrease...
Gla100、recombinant insulin analog, Aventis、Gla 100、Hoe-901、Lantus ClikSTAR、Lantus、Gla-100、Lantus SoloStar、Lantus AllSTAR、Hoe901 、Hoe 901、Optisulin、U100、insulin glargine 创新类型 创新药 药物类型 生物药 全球最高研发状态 批准上市(首次上市:1型糖尿病、2型糖尿病-美国-2000) 中国最高研发状...
Insulin glargine is a long-acting insulin used to treat type 1 and type 2 diabetes in certain patients to improve and maintain blood glucose levels. Insulin glargine is a man-made form of human insulin that is used once daily to provide a base level of insulin that keeps working for 24 ...
Insulin glargine (IGla) is a synthetic human-recombinant insulin analog that is used routinely in people as a q24h basal insulin. The 300 U/mL (U300) formulation of IGla is associated with longer duration of action and less within-day variability, making it a better basal insulin compared ...
Long-acting, biosynthetic (rDNA origin) human insulin analog.Uses for Insulin GlargineDiabetes MellitusInsulin glargine (100 units/mL; Basaglar or Lantus): Treatment of type 1 diabetes mellitus in adults and children ≥6 years of age or type 2 diabetes mellitus in adults who require long-...
Insulin used by people with diabetes can come from three sources: human (created via recombinant DNA methods), pork, or beef. Beef insulin has been discontinued in the US, and essentially all people who are newly diagnosed are placed on human insulin. ...
A Case of Successful Treatment of Immediate-type Allergy to Both Human Insulin and Insulin-analog Preparations by Desensitization with Th2 Cytokine Inhibitor(Suplatast Tosilate) The insulin analogues, aspart and lispro, have been considered safe alternatives for patients with insulin allergy, because of...
1.Preparation of a Novel Long Acting Human Insulin Analog;一种新型长效人胰岛素类似物的研制 2.Comparison of the Effect of Insulin Glargine+Glimepiride and Premixed Human Insulin Analogues in Treatment of Newly Diagnosed Type 2 Diabetes甘精胰岛素+格列美脲与预混人胰岛素类似物治疗初诊2型糖尿病的疗效比较...